Evidence map›Paper›PMID 25071572›Full record

ReviewFrontiers in pharmacology2014

Human pluripotent stem cells on artificial microenvironments: a high content perspective.

Priyalakshmi Viswanathan, Terri Gaskell, Nathalie Moens, Oliver J Culley, Darrick Hansen, Mia K R Gervasio, Yee J Yeap, Davide Danovi

Abstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Phenotypic Assessment and the Discovery of Topiramate.ACS medicinal chemistry letters · 2016
    Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Priyalakshmi ViswanathanHipSci Cell Phenotyping, Centre for Stem Cells and Regenerative Medicine, Guy's Hospital, King's College London London, UK.
Terri GaskellCell Therapy Catapult, Guy's Hospital London, UK.
Nathalie MoensHipSci Cell Phenotyping, Centre for Stem Cells and Regenerative Medicine, Guy's Hospital, King's College London London, UK.
Oliver J CulleyHipSci Cell Phenotyping, Centre for Stem Cells and Regenerative Medicine, Guy's Hospital, King's College London London, UK.
Darrick HansenHipSci Cell Phenotyping, Centre for Stem Cells and Regenerative Medicine, Guy's Hospital, King's College London London, UK.
Mia K R GervasioHipSci Cell Phenotyping, Centre for Stem Cells and Regenerative Medicine, Guy's Hospital, King's College London London, UK.
Yee J YeapHipSci Cell Phenotyping, Centre for Stem Cells and Regenerative Medicine, Guy's Hospital, King's College London London, UK.
Davide DanoviHipSci Cell Phenotyping, Centre for Stem Cells and Regenerative Medicine, Guy's Hospital, King's College London London, UK.

Funding

Wellcome Trust
6 · The paper itself

Abstract

Self-renewing stem cell populations are increasingly considered as resources for cell therapy and tools for drug discovery. Human pluripotent stem (hPS) cells in particular offer a virtually unlimited reservoir of homogeneous cells and can be differentiated toward diverse lineages. Many diseases show impairment in self-renewal or differentiation, abnormal lineage choice or other aberrant cell behavior in response to chemical or physical cues. To investigate these responses, there is a growing interest in the development of specific assays using hPS cells, artificial microenvironments and high content analysis. Several hurdles need to be overcome that can be grouped into three areas: (i) availability of robust, homogeneous, and consistent cell populations as a starting point; (ii) appropriate understanding and use of chemical and physical microenvironments; (iii) development of assays that dissect the complexity of cell populations in tissues while mirroring specific aspects of their behavior. Here we review recent progress in the culture of hPS cells and we detail the importance of the environment surrounding the cells with a focus on synthetic material and suitable high content analysis approaches. The technologies described, if properly combined, have the potential to create a paradigm shift in the way diseases are modeled and drug discovery is performed.

Indexed as

high contentmicroenvironmentphenotypingpluripotent stem cellssingle cell

Identifiers

PMID25071572
PMCPMC4078252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.